News

News

Year In Review

2022 was a year of remarkable success for Cognivia. 
Thank you to our team, partners and clients for your continued support! Here are highlights from this year – from exciting company updates to thought leadership articles.

Read More
News

Cognivia Named Finalist for the Award of ‘Scale-up de l’Année – Scale-up of the Year 2022’

We are proud to be a finalist for the award of ‘Scale-up de l’Année – Scale-up of the…

Read More
News

Cognivia CEO Dominique Demolle, PhD, Named Among 2022’s Most Inspiring People by PharmaVoice

We are pleased to share that our very own Dominique Demolle, CEO, has been recognized as one of…

Read More
News

NEW Paper: Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials

Cognivia team members contribute critical elements to a recent paper published in Innovations in Clinical Neuroscience. Cognivia co-authored a…

Read More
News

New Cognivia article in Drug Development & Discovery on “Cracking Down on the Rising Costs of Drug Development”  

Drug development has changed significantly throughout the past 2 decades – including great leaps forward in areas from…

Read More
News

New Cognivia interview in Medical News Today on COVID-19 vaccines and ‘nocebo’ effect

New research suggests that a high percentage of reported side effects from COVID-19 vaccines may be due to what’s…

Read More